• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补骨脂素与雄激素剥夺联合作用导致体内前列腺肿瘤的显著消退。

The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo.

机构信息

Vaccine Research Institute of San Diego, San Diego Science Center, San Diego, California 92109, USA.

出版信息

Prostate. 2013 Apr;73(5):489-99. doi: 10.1002/pros.22585. Epub 2012 Sep 19.

DOI:10.1002/pros.22585
PMID:22996809
Abstract

BACKGROUND

Hormonal ablation is the standard treatment for disseminated androgen-dependent prostate cancer. Although tumor growth is controlled at first, the tumor invariably recurs in the form of castration-resistant prostate cancer. This study assessed the efficacy of a new therapeutic strategy that combines plumbagin, a naturally occurring naphthoquinone, with androgen ablation.

METHODS

Viewing microscopy chambers were placed in the dorsal skinfold of mice. Syngeneic prostate tissue was grafted within the chambers and allowed to vascularize. H2B-GFP/PTEN-P2 prostate cancer cells were co-implanted on top of the grafted prostate tissue. Androgen ablation was achieved using surgical castration. Intact and castrated mice were administered plumbagin or sham treatment. Tumor growth, mitosis and apoptosis were monitored in real-time using fluorescent Intra-Vital Microscopy. The mechanism of action of plumbagin was explored using human and mouse prostate cancer cells.

RESULTS

Whereas both plumbagin and castration alone impeded tumor growth, only the combination of plumbagin and castration caused profound tumor regression in vivo, mostly due to increased apoptosis of the tumor cells. The cytotoxicity of plumbagin was not affected by androgens in vitro, suggesting that microenvironmental factors not present in culture play a crucial role in the combination effect. Plumbagin-induced cell death was mediated, at least in part, by activation of ERK and was due to generation of reactive oxygen species, because it was abolished by the anti-oxidant N-acetyl-L-cysteine.

CONCLUSION

Androgen deprivation in combination with plumbagin may provide a significant improvement over androgen deprivation alone and deserves further evaluation.

摘要

背景

激素消融是治疗扩散型雄激素依赖型前列腺癌的标准疗法。虽然肿瘤生长最初得到控制,但肿瘤总是以去势抵抗性前列腺癌的形式复发。本研究评估了一种新的治疗策略的疗效,该策略将天然萘醌化合物白花丹醌与雄激素消融相结合。

方法

在小鼠背部皮肤褶皱处放置观察显微镜室。将同种前列腺组织移植到室内并使其血管化。将 H2B-GFP/PTEN-P2 前列腺癌细胞与移植的前列腺组织顶部共植入。通过手术去势实现雄激素消融。完整和去势的小鼠给予白花丹醌或假处理。使用荧光活体内显微镜实时监测肿瘤生长、有丝分裂和细胞凋亡。使用人和小鼠前列腺癌细胞探索白花丹醌的作用机制。

结果

尽管白花丹醌和单独去势都能抑制肿瘤生长,但只有白花丹醌和去势的组合才能在体内引起肿瘤的显著消退,这主要是由于肿瘤细胞凋亡增加所致。白花丹醌的细胞毒性不受雄激素的影响,这表明培养中不存在的微环境因素在组合效应中起着至关重要的作用。白花丹醌诱导的细胞死亡至少部分是通过 ERK 的激活介导的,并且是由于活性氧的产生,因为抗氧化剂 N-乙酰-L-半胱氨酸可以消除它。

结论

雄激素剥夺联合白花丹醌可能比单独雄激素剥夺有显著改善,值得进一步评估。

相似文献

1
The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo.补骨脂素与雄激素剥夺联合作用导致体内前列腺肿瘤的显著消退。
Prostate. 2013 Apr;73(5):489-99. doi: 10.1002/pros.22585. Epub 2012 Sep 19.
2
Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.白花丹醌通过活性氧/c-Jun氨基末端激酶途径诱导人黑色素瘤A375.S2细胞的细胞周期阻滞和凋亡。
Cancer Lett. 2008 Jan 18;259(1):82-98. doi: 10.1016/j.canlet.2007.10.005. Epub 2007 Nov 19.
3
Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre-clinical study.白花丹醌提高雄激素剥夺疗法治疗前列腺癌的疗效:一项临床前研究。
Prostate. 2017 Dec;77(16):1550-1562. doi: 10.1002/pros.23428. Epub 2017 Oct 2.
4
Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.白花丹素(5-羟基-2-甲基-1,4-萘醌)在体外和体内通过c-Jun氨基末端激酶介导的丝氨酸15位点磷酸化使p53积累,从而诱导A549细胞凋亡和细胞周期停滞。
J Pharmacol Exp Ther. 2006 Aug;318(2):484-94. doi: 10.1124/jpet.105.098863. Epub 2006 Apr 21.
5
Inhibition of caspases by cytokine response modifier A blocks androgen ablation-mediated prostate cancer cell death in vivo.细胞因子反应调节因子A对胱天蛋白酶的抑制作用可阻断雄激素去除介导的前列腺癌细胞在体内的死亡。
Cancer Res. 1998 Feb 15;58(4):834-9.
6
Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).用雄激素去除与Trk酪氨酸激酶抑制剂CEP-751(KT-6587)或CEP-701(KT-5555)联合治疗的Dunning H大鼠前列腺癌在体内持续消退。
Cancer Res. 1999 May 15;59(10):2395-401.
7
Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells.白花丹醌诱导活性氧的产生,活性氧介导人宫颈癌细胞的凋亡。
Mol Carcinog. 2004 Aug;40(4):201-11. doi: 10.1002/mc.20031.
8
Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.雄激素撤除抑制肿瘤生长,并与雄激素非依赖性CWR22Rv1人前列腺癌模型中血管生成及VEGF表达的降低相关。
Anticancer Res. 2004 Jul-Aug;24(4):2135-40.
9
Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer.唑来膦酸而非生长抑素类似物在去势抵抗性前列腺癌发展的小鼠前列腺神经内分泌癌模型中发挥抗肿瘤作用。
Prostate. 2013 Apr;73(5):500-11. doi: 10.1002/pros.22590. Epub 2012 Sep 19.
10
Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.在新建立的MDA PCa 2b-hr人前列腺癌细胞亚系中,增强的雄激素受体信号传导与雄激素难治性生长相关。
Cancer Res. 2003 Sep 1;63(17):5622-8.

引用本文的文献

1
Propylene Glycol Caprylate-Based Nanoemulsion Formulation of Plumbagin: Development and Characterization of Anticancer Activity.蓖麻素基于丙二醇辛酸酯的纳米乳制剂的研制及抗癌活性的表征。
Biomed Res Int. 2022 Jan 10;2022:3549061. doi: 10.1155/2022/3549061. eCollection 2022.
2
Plumbagin-Loaded Nanoemulsion Drug Delivery Formulation and Evaluation of Antiproliferative Effect on Prostate Cancer Cells.载补骨脂素纳米乳给药制剂的制备及其对前列腺癌细胞增殖抑制作用的评价。
Biomed Res Int. 2018 Nov 11;2018:9035452. doi: 10.1155/2018/9035452. eCollection 2018.
3
Differential gene expression induced by anti-cancer agent plumbagin is mediated by androgen receptor in prostate cancer cells.
抗癌剂白花丹醌诱导的差异基因表达是通过前列腺癌细胞中的雄激素受体介导的。
Sci Rep. 2018 Feb 9;8(1):2694. doi: 10.1038/s41598-018-20451-9.
4
Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells.白花丹醌通过sirtuin1和PI3K/Akt/mTOR介导的途径诱导人前列腺癌细胞凋亡和自噬。
Drug Des Devel Ther. 2015 Mar 12;9:1511-54. doi: 10.2147/DDDT.S75976. eCollection 2015.
5
Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.白花丹醌通过靶向蛋白激酶Cε、信号转导和转录激活因子3以及上皮-间质转化标志物抑制完整和去势的PTEN基因敲除小鼠的前列腺癌发生。
Cancer Prev Res (Phila). 2015 May;8(5):375-86. doi: 10.1158/1940-6207.CAPR-14-0231. Epub 2015 Jan 27.
6
Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.白花丹醌在人前列腺癌PC-3和DU145细胞中引发差异蛋白质组学反应,主要涉及细胞周期、细胞凋亡、自噬以及上皮-间质转化途径。
Drug Des Devel Ther. 2015 Jan 7;9:349-417. doi: 10.2147/DDDT.S71677. eCollection 2015.
7
Plumbagin reduces human colon cancer cell survival by inducing cell cycle arrest and mitochondria-mediated apoptosis.白花丹素通过诱导细胞周期停滞和线粒体介导的细胞凋亡来减少人结肠癌细胞的存活。
Int J Oncol. 2014 Nov;45(5):1913-20. doi: 10.3892/ijo.2014.2592. Epub 2014 Aug 8.